ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 1006

$839K Total Retail Price of All Prescriptions

Rank: 70 out of 1006

425 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,817 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 691 620 1 8
LISINOPRIL 417 350 2 3
SIMVASTATIN 393 378 3 1
LEVOTHYROXINE SODIUM 393 389 3 2
FUROSEMIDE 384 319 5 6
METOPROLOL TARTRATE 312 296 6 7
ATORVASTATIN CALCIUM 277 261 7 5
AMLODIPINE BESYLATE 276 258 8 4
DONEPEZIL HCL 268 256 9 17
METOPROLOL SUCCINATE 260 218 10 12
ESCITALOPRAM OXALATE 234 223 11 27
TRAZODONE HCL 221 220 12 21
SERTRALINE HCL 205 202 13 19
NAMENDA 194 194 14 34
HYDROCHLOROTHIAZIDE 193 191 15 11
CYMBALTA 191 165 16 41
ATENOLOL 177 177 17 13
TAMSULOSIN HCL 168 159 18 23
POTASSIUM CHLORIDE 159 141 19 30
METFORMIN HCL 151 117 20 10
MIRTAZAPINE 147 147 21 26
DIGOXIN 146 116 22 52
OMEPRAZOLE 135 111 23 9
QUETIAPINE FUMARATE 119 118 24 45
GLIPIZIDE 118 118 25 69
RISPERIDONE 116 116 26 40
ISOSORBIDE MONONITRATE ER 98 98 27 59
OLANZAPINE 97 73 28 68
HYDROCODONE-ACETAMINOPHEN 94 93 S3 29 25
CELEBREX 93 90 30 90
OXYCODONE HCL 93 88 S2 30 54
ALENDRONATE SODIUM 90 63 32 29
PREDNISONE 90 90 32 33
ZOLPIDEM TARTRATE 88 76 34 14
CITALOPRAM HBR 82 72 35 24
CIPROFLOXACIN HCL 77 71 36 75
DIOVAN 76 76 37 16
ADVAIR DISKUS 75 70 38 37
LIDODERM 69 61 39 66
DIVALPROEX SODIUM 69 69 39 53
PAROXETINE HCL 65 61 41 62
LANTUS 64 64 42 43
ALLOPURINOL 61 34 43 31
RAMIPRIL 60 60 44 79
EXELON 60 60 44 99
GABAPENTIN 59 45 46 20
OLANZAPINE ODT 57 57 47 196
CLOPIDOGREL 54 53 48 46
RANITIDINE HCL 54 47 48 63
IPRATROPIUM-ALBUTEROL 53 53 50 73
LYRICA 53 53 50 115
SPIRIVA 52 52 52 48
OXYBUTYNIN CHLORIDE ER 51 44 53 92
VESICARE 50 50 54 163
OXYCONTIN 50 41 S2 54 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.